Genco Alfredo, Balducci Stefano, Bacci Vincenzo, Materia Alberto, Cipriano Massimiliano, Baglio Giovanni, Ribaudo Maria Cristina, Maselli Roberta, Lorenzo Michele, Basso Nicola
Department of Surgery Paride Sefanini, University La Sapienza, Rome, Italy.
Obes Surg. 2008 Aug;18(8):989-92. doi: 10.1007/s11695-007-9383-9. Epub 2008 May 16.
Very few studies have reported results of the BioEnterics Intragastric Balloon (BIB) at > or =12 months follow-up. The aim of this study is the retrospective evaluation of the results of BIB placement compared to diet regimen alone.
From January 2005 to June 2006, 130 outpatients underwent a structured diet plan with simple behavioral modification at our institutions. Controls (n = 130) were selected from the charts of patients who, during the same period, underwent BIB treatment. Patients in the outpatient group were given a structured balanced diet with a caloric intake between 1,000 and 1,200. The approximate macronutrient distribution, according the "Mediterranean diet," was 25% protein (at least 60 g/day), 20-25% lipids, and 50-55% carbohydrates. In the BIB group, patients received generic counseling for eating behavior. In both groups, we considered weight loss parameters (kilograms, percentage of excess weight loss [%EWL], body mass index [BMI], percentage of excess BMI loss [%EBL]) at 6 and 24 months from baseline and comorbidities at baseline and after 24 months. Results are expressed as mean+/-standard deviation. Statistical analysis was done by Student's t-test and chi (2)-test or Fisher's exact test. p < .05 was considered significant.
At the time of BIB removal (6 months), significantly better results in terms of weight loss in kilograms (16.7 +/- 4.7 vs. 6.6 +/- 2.6; p < 0.01), BMI (35.4 +/- 11.2 vs. 38.9 +/- 12.1; p < 0.01), %EBL (38.5 +/- 16.1 Vs 18.6 +/- 14.3; p < 0.01), and %EWL (33.9 +/- 18 vs. 24.3 +/- 17.0; p < 0.01) were observed in patients treated by intragastric balloon as compared to diet-treated patients. At 24 months from baseline, patient dropout was 1/130 (0.7%) and 25/130 (19.2%) in the BIB and diet groups, respectively (p < 0.001). At this time, patients treated with intragastric balloon have tended to regain weight, whereas diet-treated patients have already regained most of lost weight.
Although the strength of this study may be limited by its retrospective design, the results indicate that, in the short-to-medium term, BIB is significantly superior to diet in terms of weight loss.
极少有研究报告BioEnterics胃内球囊(BIB)在随访12个月及以上的结果。本研究旨在回顾性评估BIB置入与单纯饮食方案相比的效果。
2005年1月至2006年6月,130名门诊患者在我们机构接受了结构化饮食计划并进行了简单的行为改变。对照组(n = 130)从同期接受BIB治疗的患者病历中选取。门诊组患者接受结构化均衡饮食,热量摄入在1000至1200之间。根据“地中海饮食”,大致的宏量营养素分布为25%蛋白质(至少60克/天)、20 - 25%脂肪和50 - 55%碳水化合物。在BIB组,患者接受了关于饮食行为的一般咨询。两组均在基线后6个月和24个月时考虑体重减轻参数(千克、超重减轻百分比[%EWL]、体重指数[BMI]、超重BMI减轻百分比[%EBL])以及基线时和24个月后的合并症。结果以平均值±标准差表示。采用学生t检验和卡方检验或Fisher精确检验进行统计分析。p < 0.05被认为具有统计学意义。
在取出BIB时(6个月),与饮食治疗组患者相比,胃内球囊治疗患者在体重减轻千克数(16.7 ± 4.7 vs. 6.6 ± 2.6;p < 0.01)、BMI(35.4 ± 11.2 vs. 38.9 ± 12.1;p < 0.01)、%EBL(38.5 ± 16.1 vs 18.6 ± 14.3;p < 0.01)和%EWL(33.9 ± 18 vs. 24.3 ± 17.0;p < 0.01)方面的结果明显更好。从基线起24个月时,BIB组和饮食组的患者失访率分别为1/130(0.7%)和25/130(19.2%)(p < 0.001)。此时,接受胃内球囊治疗的患者有体重反弹的趋势,而饮食治疗的患者已基本恢复了大部分减轻的体重。
尽管本研究的力度可能因其回顾性设计而受到限制,但结果表明,在短期至中期,BIB在体重减轻方面明显优于饮食方案。